Implantable medical lead conductor having carbon nanotube wire

US10384050B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10384050-B2
Application numberUS-201515316482-A
CountryUS
Kind codeB2
Filing dateJun 24, 2015
Priority dateJun 25, 2014
Publication dateAug 20, 2019
Grant dateAug 20, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An implantable medical leads has a conductor that includes one or more metal wires and one or more carbon nanotube wires extending in substantially the same direction as the one or more metal wires. Such conductors may result in less MRI-induced heating at electrodes of leads than conductors that do not contain carbon nanotubes.

First claim

Opening claim text (preview).

The invention claimed is: 1. An implantable medical lead, comprising: a proximal end portion having a contact; a distal end portion having an electrode; a conductor electrically coupling the electrode to the contact; and a carbon nanotube structure coupled to the electrode and the conductor, but not the contact, wherein the carbon nanotube structure extends proximally in the lead from the electrode a distance sufficient to prevent heating of the electrode by more than 5° C. when the lead subjected to 1.5 T magnetic resonance imaging scanning at normal operating mode, and wherein heating at the electrode is tested by an in-vitro measure that is predictive of in-vivo electrode heating. 2. The implantable medical lead of claim 1 , wherein the carbon nanotube structure extends proximally in the lead from the electrode to a location more distal than the contact. 3. The implantable medical lead of claim 1 , wherein at least a portion of the conductor forms the electrode. 4. The implantable medical lead of claim 1 , wherein the conductor comprises one or more metal wires, and wherein the carbon nanotube structure comprises one or more carbon nanotube wires extending in a direction substantially the same as the one or more metal wires. 5. The implantable medical lead of claim 4 , wherein the one or more metal wires and the one or more carbon nanotube wires are twisted or braided around one another. 6. The implantable medical lead of claim 4 , wherein the one or more metal wire is formed from Cu, Au, Pt, Ag, MP35N, Ta, Nb, Ti, Mo, W, Pt—Ir, Pd, or a combination thereof. 7. An implantable medical lead, comprising: a proximal end portion having a contact; a distal end portion having an electrode; a conductor electrically coupling the electrode to the contact; and a carbon nanotube structure coupled to the electrode and the conductor, but not the contact, wherein the carbon nanotube structure extends proximally in the lead from the electrode a distance sufficient to reduce heating of the electrode by 50% or more relative to a substantially similar electrode that does not contain the carbon nanotube structure when the lead subjected to 1.5 T magnetic resonance imaging scanning or an equivalent thereof. 8. The implantable medical lead of claim 7 , wherein the conductor comprises one or more metal wires, and wherein the carbon nanotube structure comprises one or more carbon nanotube wires extending in a direction substantially the same as the one or more metal wires. 9. The implantable medical lead of claim 8 , wherein the one or more metal wires and the one or more carbon nanotube wires are twisted or braided around one another. 10. The implantable medical lead of claim 8 , wherein the one or more metal wire is formed from Cu, Au, Pt, Ag, MP35N, Ta, Nb, Ti, Mo, W, Pt—Ir, Pd, or a combination thereof.

Assignees

Inventors

Classifications

  • Provisions within MR facilities for enhancing safety during MR, e.g. reduction of the specific absorption rate [SAR], detection of ferromagnetic objects in the scanner room · CPC title

  • Invasive instruments, e.g. catheters or biopsy needles, specially adapted for tracking, guiding or visualization by NMR · CPC title

  • Monitoring of or protection against external electromagnetic fields or currents · CPC title

  • Magnetic resonance imaging [MRI] compatible leads · CPC title

  • A61N1/05Primary

    for implantation or insertion into the body, e.g. heart electrode (A61N1/06 takes precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10384050B2 cover?
An implantable medical leads has a conductor that includes one or more metal wires and one or more carbon nanotube wires extending in substantially the same direction as the one or more metal wires. Such conductors may result in less MRI-induced heating at electrodes of leads than conductors that do not contain carbon nanotubes.
Who is the assignee on this patent?
Kamarajugadda Mallika, Breyen Mark, Lyu Suping, and 4 more
What technology area does this patent fall under?
Primary CPC classification A61N1/05. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).